{"database": "lobbying", "table": "lobbying_activities", "rows": [[838113, "80cc479f-de05-426d-be75-841f730f4747", "Q3", "GILBERT'S LLP", 67876, "MYLAN LABORATORIES INC", 2009, "third_quarter", "PHA", "Reform to legislation and regulations affecting pharmaceutical drug approval and marketing", "Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE", 75000, null, 0, 0, "2009-10-19T14:19:01-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["838113"], "units": {}, "query_ms": 2.0211059600114822, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}